$2.05
-0.03 (-1.20%)
Corcept Therapeutics, Inc. (CORT)
CAPS Rating:
A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

RSS Headlines
Fool UK